These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 6986409

  • 21. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
    Borkowski A, L'hermite M, Dor P, Longeval E, Rozencweig M, Muquardt C, Van Cauter E.
    J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
    [Abstract] [Full Text] [Related]

  • 22. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
    Labrie F, Luu-The V, Labrie C, Simard J.
    Front Neuroendocrinol; 2001 Jul; 22(3):185-212. PubMed ID: 11456468
    [Abstract] [Full Text] [Related]

  • 23. Plasma levels and secretion rate of steroids with anabolic activity in man.
    Vermeulen A.
    Environ Qual Saf Suppl; 1976 Jul; (5):171-80. PubMed ID: 133798
    [Abstract] [Full Text] [Related]

  • 24. Surgical stress induces a marked and sustained increase of adrenal androgen secretion in postmenopausal women.
    Batrinos ML, Panitsa-Faflia C, Koutsoumanis C, Vourlioti T, Koutsilieris M.
    In Vivo; 1999 Jul; 13(2):147-50. PubMed ID: 10363171
    [Abstract] [Full Text] [Related]

  • 25. Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men.
    Cailleux-Bounacer A, Rohmer V, Lahlou N, Lefebvre H, Roger M, Kuhn JM.
    Int J Androl; 2009 Feb; 32(1):57-65. PubMed ID: 17931384
    [Abstract] [Full Text] [Related]

  • 26. [Ovarian suppression with Diane 35/50].
    Erdmann D, Schindler EM, Schindler AE.
    Geburtshilfe Frauenheilkd; 1994 Nov; 54(11):627-33. PubMed ID: 8719015
    [Abstract] [Full Text] [Related]

  • 27. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
    Garcia-Giralt E, Omodei Zorini C, Ferri L, Ayme Y, Carton M, Daban A, Delozier T, Fargeot P, Fumoleau P, Gorins A.
    Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
    [Abstract] [Full Text] [Related]

  • 28. Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients.
    Lundgren S, Helle SI, Lonning PE.
    Clin Cancer Res; 1996 Sep; 2(9):1515-21. PubMed ID: 9816328
    [Abstract] [Full Text] [Related]

  • 29. Sex hormone status in women suffering from rheumatoid arthritis.
    Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S.
    J Rheumatol; 1986 Dec; 13(6):1019-23. PubMed ID: 3104587
    [Abstract] [Full Text] [Related]

  • 30. Influence of radical prostatectomy on serum hormone levels.
    Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC.
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens.
    Kamenicky P, Houdoin L, Ferlicot S, Salenave S, Brailly S, Droupy S, Meduri G, Sasano H, Suzuki T, Young J, Chanson P.
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):778-88. PubMed ID: 17408424
    [Abstract] [Full Text] [Related]

  • 36. Rationale for blockade of adrenal as well as testicular androgens in the treatment of advanced prostate cancer.
    Geller J.
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):28-35. PubMed ID: 3883502
    [Abstract] [Full Text] [Related]

  • 37. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 38. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE, Clark RM, Ambus U, Weizel HA, Wadden NA, Crump M, Walde D, Tye LM, De Coster R, Bruynseels J.
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [Abstract] [Full Text] [Related]

  • 39. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
    Cohen MH, Johnson JR, Li N, Chen G, Pazdur R.
    Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
    [Abstract] [Full Text] [Related]

  • 40. Is dehydroepiandrosterone a hormone?
    Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G, Labrie C.
    J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.